These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38259849)
1. A novel gene signature related to focal adhesions for distinguishing and predicting the prognosis of lung squamous cell carcinoma. Hui G; Xie Y; Niu L; Liu J Front Med (Lausanne); 2023; 10():1284490. PubMed ID: 38259849 [TBL] [Abstract][Full Text] [Related]
2. A novel lactylation-related gene signature for effectively distinguishing and predicting the prognosis of ovarian cancer. Yu L; Jing C; Zhuang S; Ji L; Jiang L Transl Cancer Res; 2024 May; 13(5):2497-2508. PubMed ID: 38881917 [TBL] [Abstract][Full Text] [Related]
3. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C Front Immunol; 2023; 14():1236444. PubMed ID: 37841237 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel cytokine-related 8-gene signature for distinguishing and predicting the prognosis of triple-negative breast cancer. Liu X; Zhang L; Chen L Front Med (Lausanne); 2023; 10():1189361. PubMed ID: 37332770 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients. Liu X; Zhao D; Shan Y; Cui W; Xie Q; Jiang J; Peng W; Zhang C; Duan C Sci Rep; 2022 Dec; 12(1):20737. PubMed ID: 36456645 [TBL] [Abstract][Full Text] [Related]
6. Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer. Mu Y; Dong Y; Zheng M; Barr MP; Roviello G; Hu Z; Liu J J Thorac Dis; 2024 Jul; 16(7):4567-4583. PubMed ID: 39144297 [TBL] [Abstract][Full Text] [Related]
7. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma. Zhang Y; Zhou J; Li H; Liu Y; Li J BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925 [TBL] [Abstract][Full Text] [Related]
8. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma. Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375 [TBL] [Abstract][Full Text] [Related]
9. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma. Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Diao X; Guo C; Liu L; Wang G; Li S Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420 [TBL] [Abstract][Full Text] [Related]
11. Establishment of a prognostic model toward lung squamous cell carcinoma based on m Wang Y; Liu Y; Wang R; Cao F; Guan Y; Chen Y; An B; Qin S; Yao S Physiol Genomics; 2023 Oct; 55(10):427-439. PubMed ID: 37575065 [TBL] [Abstract][Full Text] [Related]
12. Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Lei K; Liang R; Tan B; Li L; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M Oxid Med Cell Longev; 2023; 2023():6811625. PubMed ID: 36703911 [TBL] [Abstract][Full Text] [Related]
13. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443 [TBL] [Abstract][Full Text] [Related]
14. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients. Yan D; Chen Y Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270 [TBL] [Abstract][Full Text] [Related]
15. Identification of a lactylation-related gene signature to characterize subtypes of hepatocellular carcinoma using bulk sequencing data. Chen Y; Chang L; Hu L; Yan C; Dai L; Shelat VG; Yarmohammadi H; Sun J J Gastrointest Oncol; 2024 Aug; 15(4):1636-1646. PubMed ID: 39279958 [TBL] [Abstract][Full Text] [Related]
16. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles. Wang W; Wang S; Chu X; Liu H; Xiang M J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242 [TBL] [Abstract][Full Text] [Related]
17. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma. Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578 [TBL] [Abstract][Full Text] [Related]
18. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma. Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analyses of a CD8 Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525 [TBL] [Abstract][Full Text] [Related]
20. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]